MoneyWorks4Me

Strides Shasun to divest its UK arm for Rs 240 crore

17 May 2016 Evaluate

Strides Shasun has received an approval for divestment of its UK arm ‘Shasun Pharma Solutions, UK’ (SPSL) for an enterprise value of GBP 25 million amounting over Rs 240 crore. The board of directors at its meeting held on May 16, 2016 has approved for the same.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and and semi-solids.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..